rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2005-8-31
|
pubmed:abstractText |
Generation of advanced glycation end products (AGE) is an inevitable process in vivo and can be accelerated under pathologic conditions such as oxidative stress, e.g. in rheumatoid arthritis (RA). This process is mediated by the AGE-specific receptor (RAGE). In this study we analysed the presence of RAGE in RA and osteoarthritic (OA) synovial tissue using immunohistology.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0172-8172
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
411-3
|
pubmed:meshHeading |
pubmed-meshheading:15045525-Aged,
pubmed-meshheading:15045525-Antigens, CD,
pubmed-meshheading:15045525-Arthritis, Rheumatoid,
pubmed-meshheading:15045525-Biological Markers,
pubmed-meshheading:15045525-Glycosylation End Products, Advanced,
pubmed-meshheading:15045525-Humans,
pubmed-meshheading:15045525-Immunoenzyme Techniques,
pubmed-meshheading:15045525-Osteoarthritis,
pubmed-meshheading:15045525-Receptors, Immunologic,
pubmed-meshheading:15045525-Synovial Membrane,
pubmed-meshheading:15045525-T-Lymphocytes
|
pubmed:year |
2005
|
pubmed:articleTitle |
Identification of the receptor for advanced glycation end products in synovial tissue of patients with rheumatoid arthritis.
|
pubmed:affiliation |
Department of Internal Medicine IV, Friedrich Schiller University, Jena, Germany. stefan.drinda@med.uni-jena.de
|
pubmed:publicationType |
Journal Article
|